RxDoctor Payments Data

Abel Torres, MD

MOHS-Micrographic Surgery · Loma Linda, CANPI 1063434223

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $790 of the $1,020 with a category attached, or 77.4%. 8 manufacturers reported payments, led by Pfizer at 25.5% of the total. Reporting peaked in 2023 at $283 and has fallen 87.1% since, to $36 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in CA, where the typical reported total is $2,212.

$1,020in general payments, 2019–2025

Across 11 payments — averaging $92.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$261
  • LEO Pharma AS$230
  • Biotronik Inc.$153
  • Aclaris Therapeutics, Inc.$124
  • Dermavant Sciences, Inc.$107
  • Lilly USA, LLC$77
  • plus $69 from 2 others
$134,583in research payments, 2019–2025

Across 16 payments — averaging $8411.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biofrontera Inc.$79K
  • Biofrontera Bioscience GmbH$56K

What the payments were for

  • Consulting fees$23023%
  • Food & beverage$79077%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,020 in reported general payments places this provider in the 25th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$16,799
Medicare patients
40
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other mohs-micrographic surgery in Loma Linda

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →